Publisher： Bentham Science Publishers
ISSN： 2212-7070
Source： Clinical Immunology, Endocrine & Metabolic Drugs, Vol.3, Iss.2, 2017-08, pp. : 117-129
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Towards a gene therapy for cystic fibrosis lung disease
By Pickles R.J.
Expert Opinion on Investigational Drugs, Vol. 6, Iss. 10, 1997-10 ,pp. :
Access to resources
Recommend
Drug Disposition in Cystic Fibrosis
By Rey E. Tréluyer J-M. Pons G.
Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. :
Personalized Drug Therapy in Cystic Fibrosis: From Fiction to Reality
Current Drug Targets, Vol. 16, Iss. 9, 2015-01 ,pp. :
Gene therapy for cystic fibrosis
By Boyd A.C.
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 1, 2001-01 ,pp. :
Gene therapy for cystic fibrosis
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. :